TABLE 3.
All Grades N (%) | Grade 3 or 4 N (%) | |
---|---|---|
Local at vaccine sites | ||
Erythema/induration | 170 (100) | 0 (0) |
Pruritus | 149 (88) | 0 (0) |
Pain, soreness, tenderness | 142 (84) | 0 (0) |
Recall induration | 14 (8) | 0 (0) |
Blister formation | 4 (2) | 0 (0) |
Hyperpigmentation | 1 (0.5) | 0 (0) |
Skin peeling | 1 (0.5) | 0 (0) |
Systemic | ||
Eosinophilia | 114 (81) | 2 (1) |
Flu-like symptoms/aches | 31 (18) | 0 (0) |
Fever | 21 (12) | 0 (0) |
Chills | 12 (7) | 0 (0) |
Fatigue | 11 (6) | 0 (0) |
Pruritus | 9 (5) | 0 (0) |
Rash | 9 (5) | 0 (0) |
Nausea | 7 (4) | 0 (0) |
Headache | 5 (3) | 0 (0) |
Leukocytosis | 4 (2) | 0 (0) |
Pruritus (not at vaccine site) | 4 (2) | 0 (0) |
Lymphadenopathy | 3 (2) | 0 (0) |
Neutrophilia | 2 (1) | 0 (0) |
Urticaria | 2 (1) | 0 (0) |
Ecchymosis | 1 (0.5) | 0 (0) |
Hyperglycemia | 1 (0.5) | 0 (0) |
Night sweats | 1 (0.5) | 0 (0) |